Related Experiment Video
Updated: Jul 11, 2025

Assessing Replication and Beta Cell Function in Adenovirally-transduced Isolated Rodent Islets
Published on: June 25, 2012
Optogenetic stimulation of vagal nerves for enhanced glucose-stimulated insulin secretion and β cell proliferation
Yohei Kawana1, Junta Imai2, Yosuke M Morizawa3
1Department of Metabolism and Diabetes, Tohoku University Graduate School of Medicine, Sendai, Japan.
Abstract:
The enhancement of insulin secretion and of the proliferation of pancreatic β cells are promising therapeutic options for diabetes. Signals from the vagal nerve regulate both processes, yet the effectiveness of stimulating the nerve is unclear, owing to a lack of techniques for doing it so selectively and prolongedly. Here we report two optogenetic methods for vagal-nerve stimulation that led to enhanced glucose-stimulated insulin secretion and to β cell proliferation in mice expressing choline acetyltransferase-channelrhodopsin 2. One method involves subdiaphragmatic implantation of an optical fibre for the photostimulation of cholinergic neurons expressing a blue-light-sensitive opsin. The other method, which suppressed streptozotocin-induced hyperglycaemia in the mice, involves the selective activation of vagal fibres by placing blue-light-emitting lanthanide microparticles in the pancreatic ducts of opsin-expressing mice, followed by near-infrared illumination. The two methods show that signals from the vagal nerve, especially from nerve fibres innervating the pancreas, are sufficient to regulate insulin secretion and β cell proliferation.
Insights
Optogenetic stimulation of the vagal nerve enhances insulin secretion and pancreatic beta cell proliferation. These novel methods offer potential new therapies for diabetes by precisely controlling nerve signals.
Area of Science:
- Neuroscience
- Endocrinology
- Biomedical Engineering
Background:
- Diabetes mellitus is a metabolic disorder characterized by impaired insulin secretion and beta cell function.
- The vagal nerve plays a crucial role in regulating insulin secretion and beta cell proliferation, but effective stimulation methods are lacking.
- Optogenetics offers precise control over neural activity, presenting a potential solution for targeted vagal nerve stimulation.
Purpose of the Study:
- To develop and evaluate optogenetic techniques for selective and prolonged vagal nerve stimulation.
- To investigate the impact of vagal nerve stimulation on glucose-stimulated insulin secretion and pancreatic beta cell proliferation.
- To assess the therapeutic potential of these optogenetic methods in a mouse model of diabetes.
Main Methods:
- Developed two optogenetic strategies for vagal nerve stimulation in mice expressing channelrhodopsin-2.
- Method 1: Subdiaphragmatic implantation of an optical fiber for blue-light photostimulation of cholinergic neurons.
- Method 2: Intra-pancreatic duct delivery of lanthanide microparticles for near-infrared activation of vagal fibers.
Main Results:
- Both optogenetic methods successfully enhanced glucose-stimulated insulin secretion.
- Optogenetic stimulation promoted pancreatic beta cell proliferation.
- The second method, utilizing near-infrared light, suppressed streptozotocin-induced hyperglycemia in mice.
- Demonstrated that vagal nerve signals, particularly those innervating the pancreas, are sufficient to regulate insulin secretion and beta cell growth.
Conclusions:
- Optogenetic stimulation of the vagal nerve is a viable strategy for enhancing insulin secretion and beta cell proliferation.
- These findings highlight the therapeutic potential of vagal nerve modulation for diabetes treatment.
- The developed optogenetic tools provide precise control for future research into neuro-endocrine regulation.
Related Concept Videos
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Insulin Secretory Vesicles
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...

